Skandinaviska Enskilda Banken (SEB)’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-240
Closed -$20.6K 868
2024
Q4
$20.6K Buy
+240
New +$26K ﹤0.01% 814
2018
Q4
Sell
-54,950
Closed -$1.29M 813
2018
Q3
$1.29M Hold
54,950
0.01% 622
2018
Q2
$1.27M Hold
54,950
0.01% 577
2018
Q1
$1.35M Hold
54,950
0.01% 509
2017
Q4
$1.48M Hold
54,950
0.01% 520
2017
Q3
$1.32M Sell
54,950
-14,250
-21% -$322K 0.01% 575
2017
Q2
$1.48M Hold
69,200
0.01% 527
2017
Q1
$1.19M Hold
69,200
0.01% 581
2016
Q4
$1.24M Hold
69,200
0.01% 497
2016
Q3
$1.44M Hold
69,200
0.02% 543
2016
Q2
$1.86M Hold
69,200
0.02% 468
2016
Q1
$1.88M Buy
+69,200
New +$1.85M 0.02% 446

Other funds holding NVO

Skandinaviska Enskilda Banken (SEB)'s NVO Position: Q1 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 240 shares — an estimated $20.6K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in NVO in Q1 2016 and held it in 12 quarters. The position peaked at $1.88M in Q1 2016. 1,529 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 240 Novo Nordisk shares in Q1 2025, an estimated $20.6K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Novo Nordisk in Q1 2016 and held it in 12 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Novo Nordisk position peaked at $1.88M in Q1 2016.
  • 1,529 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2025, filed 7 May 2025.